Items where Author is "Seifert, K"
Up a level |
Jump to: Article
Number of items: 15.
Article
Das, S;
Freier, A;
Boussoffara, T;
Das, S;
Oswald, D;
Losch, FO;
Selka, M;
Sacerdoti-Sierra, N;
Schönian, G;
Wiesmüller, KH;
+10 more...
Seifert, K;
Schroff, M;
Juhls, C;
Jaffe, CL;
Roy, S;
Das, P;
Louzir, H;
Croft, SL;
Modabber, F;
Walden, P;
(2014)
Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis.
Science translational medicine, 6 (234).
234ra56.
ISSN 1946-6234
DOI: https://doi.org/10.1126/scitranslmed.3008222
Full text not available from this repository.
Kaur, H;
Seifert, K;
Hawkes, GE;
Coumbarides, GS;
Alvar, J;
Croft, SL;
(2015)
Chemical and Bioassay Techniques to Authenticate Quality of the Anti-Leishmanial Drug Miltefosine.
The American journal of tropical medicine and hygiene, 92 (6 Suppl).
pp. 31-8.
ISSN 0002-9637
DOI: https://doi.org/10.4269/ajtmh.14-0586
Koniordou, M;
Patterson, S;
Wyllie, S;
Seifert, K;
(2017)
Snapshot profiling of anti-leishmanial potency of lead compounds and drug candidates against intracellular L. donovani amastigotes with focus on human derived host cells.
Antimicrobial agents and chemotherapy, 61 (3).
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.01228-16
Lamour, SD;
Veselkov, KA;
Posma, JM;
Giraud, E;
Rogers, ME;
Croft, S;
Marchesi, JR;
Holmes, E;
Seifert, K;
Saric, J;
(2014)
Metabolic, Immune, and Gut Microbial Signals Mount a Systems Response to Leishmania major Infection.
Journal of proteome research, 14 (1).
pp. 318-329.
ISSN 1535-3893
DOI: https://doi.org/10.1021/pr5008202
Full text not available from this repository.
Meredith, EL;
Kumar, A;
Konno, A;
Szular, J;
Alsford, S;
Seifert, K;
Horn, D;
Wilkinson, SR;
(2017)
Distinct activation mechanisms trigger the trypanocidal activity of DNA damaging prodrugs.
Molecular microbiology.
ISSN 0950-382X
DOI: https://doi.org/10.1111/mmi.13767
Nicoletti, S;
Seifert, K;
Gilbert, IH;
(2009)
N-(2-hydroxypropyl)methacrylamide-amphotericin B (HPMA-AmB) copolymer conjugates as antileishmanial agents.
International journal of antimicrobial agents, 33 (5).
pp. 441-8.
ISSN 0924-8579
DOI: https://doi.org/10.1016/j.ijantimicag.2008.10.013
Perez-Victoria, FJ;
Sanchez-Canete, MP;
Seifert, K;
Croft, SL;
Sundar, S;
Castanys, S;
Gamarro, F;
(2006)
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.
Drug resistance updates, 9 (1-2).
pp. 26-39.
ISSN 1368-7646
DOI: https://doi.org/10.1016/j.drup.2006.04.001
Full text not available from this repository.
Riede, O;
Seifert, K;
Oswald, D;
Endmann, A;
Hock, C;
Winkler, A;
Salguero, FJ;
Schroff, M;
Croft, SL;
Juhls, C;
(2015)
Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine.
Gene therapy, 22 (8).
pp. 628-35.
ISSN 0969-7128
DOI: https://doi.org/10.1038/gt.2015.35
Salguero, FJ;
Garcia-Jimenez, WL;
Lima, I;
Seifert, K;
(2018)
Histopathological and immunohistochemical characterisation of hepatic granulomas in Leishmania donovani-infected BALB/c mice: a time-course study.
Parasites & vectors, 11 (1).
p. 73.
ISSN 1756-3305
DOI: https://doi.org/10.1186/s13071-018-2624-z
Seifert, K;
Juhls, C;
Salguero, FJ;
Croft, SL;
(2015)
Sequential chemo-immunotherapy of experimental visceral leishmaniasis using single low dose liposomal amphotericin B and a novel DNA vaccine candidate.
Antimicrobial agents and chemotherapy, 59 (9).
pp. 5819-23.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.00273-15
Full text not available from this repository.
Seifert, K;
Perez-Victoria, FJ;
Stettler, M;
Sánchez-Cañete, MP;
Castanys, S;
Gamarro, F;
Croft, SL;
(2007)
Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
International journal of antimicrobial agents, 30 (3).
pp. 229-35.
ISSN 0924-8579
DOI: https://doi.org/10.1016/j.ijantimicag.2007.05.007
Full text not available from this repository.
Voak, AA;
Harris, A;
Qaiser, Z;
Croft, SL;
Seifert, K;
(2017)
Treatment of experimental visceral leishmaniasis with single-dose liposomal amphotericin B - pharmacodynamics and biodistribution at different stages of disease.
Antimicrobial agents and chemotherapy, 61 (9).
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.00497-17
Voak, AA;
Seifert, K;
Helsby, NA;
Wilkinson, SR;
(2013)
Evaluating aziridinyl nitrobenzamide compounds as leishmanicidal prodrugs.
Antimicrobial agents and chemotherapy, 58 (1).
pp. 370-7.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.01459-13
Full text not available from this repository.
Voak, AA;
Standing, JF;
Sepúlveda, N;
Harris, A;
Croft, SL;
Seifert, K;
(2018)
Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages.
The Journal of antimicrobial chemotherapy.
ISSN 0305-7453
DOI: https://doi.org/10.1093/jac/dky014
Walochnik, J;
Duchêne, M;
Seifert, K;
Obwaller, A;
Hottkowitz, T;
Wiedermann, G;
Eibl, H;
Aspöck, H;
(2002)
Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp.
Antimicrobial agents and chemotherapy, 46 (3).
pp. 695-701.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.46.3.695-701.2002
Full text not available from this repository.